Endicott Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-30,000
Closed -$1.63M 17
2017
Q1
$1.63M Buy
+30,000
New +$1.65M 0.84% 15

Other funds holding BMY

Endicott Management's BMY Position: Q2 2017 in Review

Endicott Management sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 30,000 shares — an estimated $1.63M sold.

Endicott Management first reported a position in BMY in Q1 2017 and held it in 1 quarter. The position peaked at $1.63M in Q1 2017. 1,595 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

  • Endicott Management reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
  • Endicott Management sold 30,000 Bristol-Myers Squibb shares in Q2 2017, an estimated $1.63M.
  • Endicott Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 1 quarter.
  • Endicott Management's Bristol-Myers Squibb position peaked at $1.63M in Q1 2017.
  • 1,595 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Endicott Management's 13F filing for Q2 2017, filed 14 Aug 2017.